FDA Grants MIWG Petitions Requesting a Full Review of Agency Regulations and Policies on the Communication of Medical and Scientific Information about Investigational Products and Unapproved New Uses
Major FDA Announcement on OTCs
FDA to Issue Final Guidance on Dear HCP Letters
FDA Issues Social Media Draft Guidance
Sample Reporting Under Section 6004 of the Affordable Care Act
Recent Janssen/J&J Risperdal State Settlement Restricts Certain Promotional Activities for Atypical Antipsychotics
Subscribe: Subscribe via RSS
Blogs
Firm/Org